Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL7772649 | 1.00 | TSHR (0.62) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene SCHEMBL2777710 | 1.00 | TSHR (0.62) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene SCHEMBL2776408 | 1.00 | TSHR (0.62) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene SCHEMBL2775625 | 1.00 | TSHR (0.62) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene SCHEMBL27824830 | 0.97 | TSHR (0.59) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL2933671 | 0.94 | — | — | |
| SCHEMBL4623846 | 0.94 | — | — | |
| SCHEMBL4895623 | 0.94 | TSHR (0.68) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL15245 | 0.94 | — | — | |
| SCHEMBL2933673 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1034 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4631536-A1 | CROSS-LINKED HYALURONIC ACID GEL HAVING GOOD SPREADABILITY AND STABILITY, AND USE THEREOF | Medytox Inc. (KR) | 2025-10-15 | — | — | EP | claimed |
| CN-120041130-A | High-performance anhydride epoxy pouring sealant and preparation method thereof | 昆山端点新材料科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| US-20240216576-A1 | HYALURONIC ACID CROSS-LINKED PRODUCT, AND FILLER COMPOSITION COMPRISING SAME | MEDYTOX INC. (KR) | 2024-07-04 | — | — | US | claimed |
| WO-2024123007-A1 | CROSS-LINKED HYALURONIC ACID GEL HAVING GOOD SPREADABILITY AND STABILITY, AND USE THEREOF | (주)메디톡스 | 2024-06-13 | — | — | WO | claimed |
| EP-4356935-A1 | HYALURONIC ACID CROSS-LINKED PRODUCT, AND FILLER COMPOSITION COMPRISING SAME | Medytox Inc. (KR) | 2024-04-24 | — | — | EP | claimed |
| CN-117500534-A | Hyaluronic acid crosslinked body and filler composition comprising same | 玫帝托克斯股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20230126726-A1 | CROSSLINKED HYALURONIC ACID AND USE THEREOF | MEDYTOX INC. (KR) | 2023-04-27 | — | — | US | claimed |
| EP-4119585-A1 | CROSSLINKED HYALURONIC ACID AND USE THEREOF | Medytox Inc. (KR) | 2023-01-18 | — | — | EP | claimed |
| WO-2022265380-A1 | HYALURONIC ACID CROSS-LINKED PRODUCT, AND FILLER COMPOSITION COMPRISING SAME | (주)메디톡스 | 2022-12-22 | — | — | WO | claimed |
| CN-115279798-A | Cross-linked hyaluronic acid, and use thereof | 玫帝托克斯股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| EP-0975378-A1 | METHODS FOR ACTIVELY BINDING HEPARIN TO CROSS-LINKED BIOLOGICAL TISSUES | BAXTER INTERNATIONAL INC. (US) | 2000-02-02 | — | — | EP | claimed |
| US-5891196-A | Method for actively binding heparin to crosslinked biological tissues | BAXTER INTERNATIONAL INC. (US) | 1999-04-06 | — | — | US | claimed |
| WO-1998046288-A1 | METHODS FOR ACTIVELY BINDING HEPARIN TO CROSS-LINKED BIOLOGICAL TISSUES | BAXTER INTERNATIONAL INC. (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0367219-B1 | Polyorganosiloxane series thermoplastic resin and composition thereof | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1994-08-31 | — | — | EP | claimed |
| US-5250615-A | Slidability; abrasion, weather, cold and impact resistance | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1993-10-05 | — | — | US | claimed |
| EP-0294062-B1 | RESIN COMPOSITIONS AND MOLDED PRODUCTS THEREOF | UBE INDUSTRIES, LTD. (JP) | 1993-09-01 | — | — | EP | claimed |
| US-5147947-A | Graft polymer containing vinyl monomer; friction resistance | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1992-09-15 | — | — | US | claimed |
| EP-0367219-A2 | Polyorganosiloxane series thermoplastic resin and composition thereof | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1990-05-09 | — | — | EP | claimed |
| CN-88101715-A | Improved polyacetal molding composition | — | 1988-10-19 | — | — | CN | claimed |
| US-4517348-A | VINYL CARBOXYLATE, ALKOXYALKYL ACRYLATE AND GLYCIDYL POLYMERS | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-05-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230126726-A1 | CROSSLINKED HYALURONIC ACID AND USE THEREOF | CD44, COL2A1, COL14A1 | TSHR 2088/4885ALDH1A1 403/4885MAPK1 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.